Pegylated interferon alpha-1b

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/00 (2006.01)

Patent

CA 2572751

The invention provides PEG-IFN .alpha.-lb conjugates, where a PEG moiety is covalently bound to Cys86 of human IFN .alpha. -lb conjugates. A pharmaceutical composition and a method for treating inflammatory diseases, infections, and cancer are also provided. The invention further relates to a method for the modification of interferons by conjugation of a PEG moiety to free cysteine residues in interferon molecules.

Cette invention concerne des conjugués PEG-IFN a-1b, dans lesquels un fragment PEG est lié par covalence à la Cys86 de conjugués IFN a -1b humains. La présente invention concerne également une composition pharmaceutique et une méthode permettant de traiter des maladies inflammatoires, des infections, et un cancer. En outre, cette invention concerne une méthode permettant de modifier les interférons par conjugaison d'un fragment PEG avec des résidus de cystéine libres dans des molécules de l'interféron.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pegylated interferon alpha-1b does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pegylated interferon alpha-1b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pegylated interferon alpha-1b will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1679632

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.